Treatment.Com International Inc.
Treatment.Com International Inc. (TRUE.CN) Stock Competitors & Peer Comparison
See (TRUE.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRUE.CN | CA$0.51 | -1.92% | 38.5M | -2.68 | -CA$0.19 | N/A |
| VHI.TO | CA$6.90 | -1.15% | 436.3M | 69.00 | CA$0.10 | N/A |
| CARE.TO | CA$5.15 | +0.10% | 345.7M | -17.15 | -CA$0.30 | N/A |
| KSI.TO | CA$3.57 | +2.29% | 342M | -178.50 | -CA$0.02 | N/A |
| AIDR.CN | CA$0.60 | -6.25% | 51M | -3.75 | -CA$0.16 | N/A |
| HS.CN | CA$0.53 | +3.92% | 29M | -3.31 | -CA$0.16 | N/A |
| RYAH.CN | CA$0.03 | +0.00% | 11.2M | -0.15 | -CA$0.17 | N/A |
| UDOC.CN | CA$0.12 | -11.54% | 9.9M | -2.87 | -CA$0.04 | N/A |
| DMED.CN | CA$0.09 | -10.00% | 8.3M | -4.50 | -CA$0.02 | N/A |
| TELE.CN | CA$0.09 | N/A | 7.6M | -0.13 | -CA$0.69 | N/A |
Stock Comparison
TRUE.CN vs VHI.TO Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, VHI.TO has a market cap of 436.3M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while VHI.TO trades at CA$6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas VHI.TO's P/E ratio is 69.00. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to VHI.TO's ROE of +0.03%. Regarding short-term risk, TRUE.CN is more volatile compared to VHI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check VHI.TO's competition here
TRUE.CN vs CARE.TO Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, CARE.TO has a market cap of 345.7M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while CARE.TO trades at CA$5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, TRUE.CN is more volatile compared to CARE.TO. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check CARE.TO's competition here
TRUE.CN vs KSI.TO Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, KSI.TO has a market cap of 342M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while KSI.TO trades at CA$3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas KSI.TO's P/E ratio is -178.50. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to KSI.TO's ROE of -0.04%. Regarding short-term risk, TRUE.CN is less volatile compared to KSI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TRUE.CN.Check KSI.TO's competition here
TRUE.CN vs AIDR.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, AIDR.CN has a market cap of 51M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while AIDR.CN trades at CA$0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas AIDR.CN's P/E ratio is -3.75. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to AIDR.CN's ROE of -1.90%. Regarding short-term risk, TRUE.CN is less volatile compared to AIDR.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TRUE.CN.Check AIDR.CN's competition here
TRUE.CN vs HS.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, HS.CN has a market cap of 29M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while HS.CN trades at CA$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas HS.CN's P/E ratio is -3.31. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to HS.CN's ROE of -1.34%. Regarding short-term risk, TRUE.CN and HS.CN have similar daily volatility (3.85).Check HS.CN's competition here
TRUE.CN vs RYAH.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, RYAH.CN has a market cap of 11.2M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while RYAH.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, TRUE.CN is more volatile compared to RYAH.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check RYAH.CN's competition here
TRUE.CN vs UDOC.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, UDOC.CN has a market cap of 9.9M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while UDOC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas UDOC.CN's P/E ratio is -2.87. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to UDOC.CN's ROE of +62.39%. Regarding short-term risk, TRUE.CN is more volatile compared to UDOC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check UDOC.CN's competition here
TRUE.CN vs DMED.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, DMED.CN has a market cap of 8.3M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while DMED.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas DMED.CN's P/E ratio is -4.50. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to DMED.CN's ROE of +5.27%. Regarding short-term risk, TRUE.CN is more volatile compared to DMED.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check DMED.CN's competition here
TRUE.CN vs TELE.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, TELE.CN has a market cap of 7.6M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while TELE.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to TELE.CN's ROE of +1.60%. Regarding short-term risk, TRUE.CN is more volatile compared to TELE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check TELE.CN's competition here
TRUE.CN vs NARA.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, NARA.CN has a market cap of 6.6M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while NARA.CN trades at CA$0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas NARA.CN's P/E ratio is -1.52. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to NARA.CN's ROE of +1.62%. Regarding short-term risk, TRUE.CN is more volatile compared to NARA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check NARA.CN's competition here
TRUE.CN vs LYNX.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, LYNX.CN has a market cap of 6.4M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while LYNX.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas LYNX.CN's P/E ratio is -0.29. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to LYNX.CN's ROE of -1.35%. Regarding short-term risk, TRUE.CN is more volatile compared to LYNX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check LYNX.CN's competition here
TRUE.CN vs AIML.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, AIML.CN has a market cap of 5.9M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while AIML.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas AIML.CN's P/E ratio is -1.17. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to AIML.CN's ROE of -3.31%. Regarding short-term risk, TRUE.CN is more volatile compared to AIML.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check AIML.CN's competition here
TRUE.CN vs NDAT.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, NDAT.CN has a market cap of 2.7M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while NDAT.CN trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas NDAT.CN's P/E ratio is -3.25. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to NDAT.CN's ROE of -0.34%. Regarding short-term risk, TRUE.CN is less volatile compared to NDAT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TRUE.CN.Check NDAT.CN's competition here
TRUE.CN vs LITE.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, LITE.CN has a market cap of 2M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while LITE.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas LITE.CN's P/E ratio is -0.50. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, TRUE.CN is more volatile compared to LITE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check LITE.CN's competition here
TRUE.CN vs CBP.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, CBP.CN has a market cap of 1.7M. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while CBP.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas CBP.CN's P/E ratio is -1.00. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to CBP.CN's ROE of +0.17%. Regarding short-term risk, TRUE.CN is more volatile compared to CBP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check CBP.CN's competition here
TRUE.CN vs TMED.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, TMED.CN has a market cap of 929.3K. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while TMED.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas TMED.CN's P/E ratio is -0.30. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to TMED.CN's ROE of +0.80%. Regarding short-term risk, TRUE.CN is less volatile compared to TMED.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TRUE.CN.Check TMED.CN's competition here
TRUE.CN vs CGN.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, CGN.CN has a market cap of 895.9K. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while CGN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas CGN.CN's P/E ratio is -0.13. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, TRUE.CN is more volatile compared to CGN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check CGN.CN's competition here
TRUE.CN vs KETA.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, KETA.CN has a market cap of 532.7K. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while KETA.CN trades at CA$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas KETA.CN's P/E ratio is -2.00. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to KETA.CN's ROE of +0.01%. Regarding short-term risk, TRUE.CN is more volatile compared to KETA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check KETA.CN's competition here
TRUE.CN vs WTEQ.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, WTEQ.CN has a market cap of 0. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while WTEQ.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas WTEQ.CN's P/E ratio is 2.00. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to WTEQ.CN's ROE of -1.70%. Regarding short-term risk, Volatility data is not available for a full comparison. TRUE.CN has daily volatility of 3.85 and WTEQ.CN has daily volatility of N/A.Check WTEQ.CN's competition here
TRUE.CN vs MEND.CN Comparison April 2026
TRUE.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUE.CN stands at 38.5M. In comparison, MEND.CN has a market cap of 0. Regarding current trading prices, TRUE.CN is priced at CA$0.51, while MEND.CN trades at CA$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUE.CN currently has a P/E ratio of -2.68, whereas MEND.CN's P/E ratio is N/A. In terms of profitability, TRUE.CN's ROE is -3.04%, compared to MEND.CN's ROE of -1.68%. Regarding short-term risk, TRUE.CN is more volatile compared to MEND.CN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUE.CN.Check MEND.CN's competition here